How do you know anything is real? Some things you can see directly, like your fingers. Other things, like your chin, you need a mirror or a camera to see. Other things can’t be seen, but you believe ...
The true nature of our universe as been an open debate for millennia, and recently, scientists and philosophers have pondered whether it might be a hyper-realistic simulation perpetuated by some super ...
A groundbreaking international study has shown that a 2-in-1 budesonide-formoterol inhaler is far more effective than the standard salbutamol inhaler in children with mild asthma, cutting attacks by ...
See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. Scientists have found a new treatment for people with asthma and ...
Nearly 28 million people in the U.S. have asthma, or about one in 12 people — and depending on where you live, the condition may be more difficult to manage. The Asthma and Allergy Foundation of ...
Most people with asthma are able to control their symptoms by using inhaled medicines each day. But for some people with severe asthma, inhaled medicines are not enough to keep symptoms under control.
Credit: Getty Images The GINA 2024 asthma update includes new guidance on medications, monitoring, treatment goals, remission, cough variant asthma, children, and more. The Global Initiative for ...
Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...
Starting Saturday, the cost of inhalers will fall for many Americans, as new out-of-pocket price caps go into effect for the asthma medications from AstraZeneca and Boehringer Ingelheim. Subscribe to ...
Scientists have discovered a new cause for asthma that sparks hope for treatment that could prevent the life-threatening disease. Scientists at King's College London have discovered a new cause for ...
The price of asthma medication has soared in the U.S. over the past decade and a half. I’m a health law professor at Villanova University, where I study whether patients can get the medicines they ...
In 1998 an asthma and allergy drug called montelukast hit the U.S. market under the name Singulair. In the years that followed, commercials filled with flowers and cats proclaimed that it was “a ...